Cargando…

Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy

Optimal patient selection for cardiac resynchronization therapy is crucial. There are several concerns that allow to better clarify the association between the ischemic etiology of heart failure and the response to cardiac resynchronization therapy. The type of ischemic coronary disease has an impac...

Descripción completa

Detalles Bibliográficos
Autor principal: Imamura, Teruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143928/
https://www.ncbi.nlm.nih.gov/pubmed/32143409
http://dx.doi.org/10.3390/medicina56030110
_version_ 1783519729460183040
author Imamura, Teruhiko
author_facet Imamura, Teruhiko
author_sort Imamura, Teruhiko
collection PubMed
description Optimal patient selection for cardiac resynchronization therapy is crucial. There are several concerns that allow to better clarify the association between the ischemic etiology of heart failure and the response to cardiac resynchronization therapy. The type of ischemic coronary disease has an impact on the responses to cardiac resynchronization therapy. The prognostic impact of cardiac resynchronization therapy on cardiac death including heart transplantation and durable ventricular assist device implantation is another concern.
format Online
Article
Text
id pubmed-7143928
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71439282020-04-13 Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy Imamura, Teruhiko Medicina (Kaunas) Letter Optimal patient selection for cardiac resynchronization therapy is crucial. There are several concerns that allow to better clarify the association between the ischemic etiology of heart failure and the response to cardiac resynchronization therapy. The type of ischemic coronary disease has an impact on the responses to cardiac resynchronization therapy. The prognostic impact of cardiac resynchronization therapy on cardiac death including heart transplantation and durable ventricular assist device implantation is another concern. MDPI 2020-03-04 /pmc/articles/PMC7143928/ /pubmed/32143409 http://dx.doi.org/10.3390/medicina56030110 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Letter
Imamura, Teruhiko
Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
title Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
title_full Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
title_fullStr Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
title_full_unstemmed Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
title_short Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
title_sort ischemic etiology and clinical outcomes following cardiac resynchronization therapy
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143928/
https://www.ncbi.nlm.nih.gov/pubmed/32143409
http://dx.doi.org/10.3390/medicina56030110
work_keys_str_mv AT imamurateruhiko ischemicetiologyandclinicaloutcomesfollowingcardiacresynchronizationtherapy